MedPath

GILEAD SCIENCES SINGAPORE PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

HSA:15

Drug Approvals

Sunlenca film-coated tablet 300mg

Approval Date
Feb 27, 2025
HSA

Sunlenca solution for injection 463.5mg/1.5ml

Approval Date
Feb 27, 2025
HSA

TRODELVY POWDER FOR SOLUTION FOR INFUSION 180 MG/VIAL

Approval Date
Jan 31, 2022
HSA

VEKLURY® LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIAL

Approval Date
Jun 10, 2020
HSA

VOSEVI FILM-COATED TABLETS 400MG/100MG/100MG

Approval Date
May 31, 2019
HSA

BIKTARVY FILM-COATED TABLETS 50MG/200MG/25MG

Approval Date
Jan 2, 2019
HSA

VEMLIDY FILM COATED TABLET 25 MG

Approval Date
Dec 11, 2017
HSA

EPCLUSA TABLET 400MG/100MG

Approval Date
Oct 19, 2017
HSA

DESCOVY FILM COATED TABLET 200 MG/25 MG

Approval Date
Aug 21, 2017
HSA

DESCOVY FILM COATED TABLET 200 MG/10 MG

Approval Date
Aug 21, 2017
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.